BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:30 PM
Sep 27, 2012
 |  BC Extra  |  Company News

PeptiDream in discovery deal with GSK

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) partnered with PeptiDream Inc. (Tokyo, Japan) to discover and develop peptide therapeutics against the pharma's targets using the biotech's Peptide Discovery Platform...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >